CVS suspends sales of the popular heartburn drug Zantac, as well as its own generic, following FDA alert that the medicine contained a possible carcinogen.
CVS Health Corp. has suspended sales of the popular heartburn drug Zantac, as well as its own generic, called ranitidine, following a Food and Drug Administration alert earlier this month that the medicine contained a possible carcinogen.
"Zantac brand products and CVS brand ranitidine products have not been recalled, and the FDA is not recommending that patients stop taking ranitidine at this time," the company said in a statement. Customers who previously purchased the heartburn medicine at CVS can return it to the stores for a refund.
Results from FDA lab tests showed some heartburn pills contained an impurity called N-nitrosodimethylamine in small amounts. As a probable carcinogen, NDMA may be capable of increasing cancer risk when taken in high doses over a long period of time.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Zantac cancer warning: Why CVS is recalling heartburn drug and what alternative medication you can take'CVS Pharmacy has suspended the sale of all Zantac brand and CVS Health brand ranitidine products until further notice,' a spokesperson for the brand wrote in a press release.
Read more »
CVS Pulls Zantac, Here Is The Latest On Cancer ConcernsIf you bought these ranitidine products, you can return them as long as you have your very long receipt.
Read more »
CVS suspends sales of Zantac brand due to contaminant fearsCVS said the move to suspend sales of the over-the-counter heartburn drug was taken out of caution while the FDA continues its review.
Read more »
CVS pulls Zantac and similar heartburn drugs because of cancer worriesCVS Pharmacy has stopped selling Zantac, as well as its generic version of the heartburn medication, over concerns that they might contain a substance that could cause cancer.
Read more »